Your browser doesn't support javascript.
loading
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency.
Milardi, Giulia; Di Lorenzo, Biagio; Gerosa, Jolanda; Barzaghi, Federica; Di Matteo, Gigliola; Omrani, Maryam; Jofra, Tatiana; Merelli, Ivan; Barcella, Matteo; Filippini, Matteo; Conti, Anastasia; Ferrua, Francesca; Pozzo Giuffrida, Francesco; Dionisio, Francesca; Rovere-Querini, Patrizia; Marktel, Sarah; Assanelli, Andrea; Piemontese, Simona; Brigida, Immacolata; Zoccolillo, Matteo; Cirillo, Emilia; Giardino, Giuliana; Danieli, Maria Giovanna; Specchia, Fernando; Pacillo, Lucia; Di Cesare, Silvia; Giancotta, Carmela; Romano, Francesca; Matarese, Alessandro; Chetta, Alfredo Antonio; Trimarchi, Matteo; Laurenzi, Andrea; De Pellegrin, Maurizio; Darin, Silvia; Montin, Davide; Marinoni, Maddalena; Dellepiane, Rosa Maria; Sordi, Valeria; Lougaris, Vassilios; Vacca, Angelo; Melzi, Raffaella; Nano, Rita; Azzari, Chiara; Bongiovanni, Lucia; Pignata, Claudio; Cancrini, Caterina; Plebani, Alessandro; Piemonti, Lorenzo; Petrovas, Constantinos; Di Micco, Raffaella.
Afiliación
  • Milardi G; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Di Lorenzo B; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Gerosa J; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Barzaghi F; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Di Matteo G; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Omrani M; Department of Systems Medicine, University of Rome Tor Vergata, Via Cracovia 50, Rome, 00133, Italy.
  • Jofra T; Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio 4, Rome, 00165, Italy.
  • Merelli I; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Barcella M; Department of Computer Science, Systems and Communication, University of Milano-Bicocca, Piazza dell'Ateneo Nuovo 1, Milan, 20126, Italy.
  • Filippini M; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Conti A; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Ferrua F; Department of Bioinformatics, Institute for Biomedical Technologies, National Research Council, Via Fratelli Cervi 93, Segrate, 20090, Italy.
  • Pozzo Giuffrida F; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Dionisio F; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Rovere-Querini P; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Marktel S; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Assanelli A; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Piemontese S; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Brigida I; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Zoccolillo M; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Cirillo E; Department of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Giardino G; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Danieli MG; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Specchia F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Pacillo L; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Di Cesare S; Pathogenesis and therapy of primary immunodeficiencies Unit, San Raffaele Telethon Institute for Gene Therapy, Sr-TIGET, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Giancotta C; Department of Translational Medical Sciences, Section of Pediatrics, Federico II University of Naples, Corso Umberto I, 40, 80138, Italy.
  • Romano F; Department of Translational Medical Sciences, Section of Pediatrics, Federico II University of Naples, Corso Umberto I, 40, 80138, Italy.
  • Matarese A; Department of Clinical and Molecular Sciences, Marche Polytechnic University of Ancona, Clinica Medica, Via Tronto 10/a, Ancona, 60126, Italy.
  • Chetta AA; Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Via Giuseppe Massarenti 9, Bologna, 40138, Italy.
  • Trimarchi M; Department of Systems Medicine, University of Rome Tor Vergata, Via Cracovia 50, Rome, 00133, Italy.
  • Laurenzi A; Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio 4, Rome, 00165, Italy.
  • De Pellegrin M; Department of Systems Medicine, University of Rome Tor Vergata, Via Cracovia 50, Rome, 00133, Italy.
  • Darin S; Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio 4, Rome, 00165, Italy.
  • Montin D; Department of Systems Medicine, University of Rome Tor Vergata, Via Cracovia 50, Rome, 00133, Italy.
  • Marinoni M; Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio 4, Rome, 00165, Italy.
  • Dellepiane RM; Pediatric Immunology Division, Department of Pediatrics, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, Florence, 50139, Italy.
  • Sordi V; Department of Respiratory Medicine, Santi Antonio, Biagio and Cesare Arrigo Hospital, Via Venezia 16, Alessandria, 15121, Italy.
  • Lougaris V; Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Str. dell'Università 12, Parma, 43121, Italy.
  • Vacca A; Otorhinolaryngology Unit, Head and Neck Department, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milan, 20132, Italy.
  • Melzi R; Pathology Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Nano R; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Azzari C; Unit of Orthopaedics, IRCCS San Raffaele Scientific Institute, Via Olgettina 60, Milan, 20132, Italy.
  • Bongiovanni L; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Pignata C; Department of Pediatrics and Public Health, Regina Margherita Hospital, Piazza Polonia 94, Turin, 10126, Italy.
  • Cancrini C; Pediatric Unit, Ospedale "F. Del Ponte", Via Filippo del Ponte 19, Varese, 21100, Italy.
  • Plebani A; Department of Pediatrics, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35, Milan, 20122, Italy.
  • Piemonti L; Division of Immunology, Transplantation, and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy.
  • Petrovas C; Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, University of Brescia, Piazza del Mercato 15, Brescia, 25121, Italy.
  • Di Micco R; Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Piazza Umberto I, 1, Bari, 70121, Italy.
Eur J Immunol ; 52(7): 1171-1189, 2022 07.
Article en En | MEDLINE | ID: mdl-35562849
ABSTRACT
Common variable immunodeficiency (CVID) is the most frequent primary antibody deficiency whereby follicular helper T (Tfh) cells fail to establish productive responses with B cells in germinal centers. Here, we analyzed the frequency, phenotype, transcriptome, and function of circulating Tfh (cTfh) cells in CVID patients displaying autoimmunity as an additional phenotype. A group of patients showed a high frequency of cTfh1 cells and a prominent expression of PD-1 and ICOS as well as a cTfh mRNA signature consistent with highly activated, but exhausted, senescent, and apoptotic cells. Plasmatic CXCL13 levels were elevated in this group and positively correlated with cTfh1 cell frequency and PD-1 levels. Monoallelic variants in RTEL1, a telomere length- and DNA repair-related gene, were identified in four patients belonging to this group. Their blood lymphocytes showed shortened telomeres, while their cTfh were more prone to apoptosis. These data point toward a novel pathogenetic mechanism in CVID, whereby alterations in DNA repair and telomere elongation might predispose to antibody deficiency. A Th1, highly activated but exhausted and apoptotic cTfh phenotype was associated with this form of CVID.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia